Massachusetts Financial Services’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-36,125
| Closed | -$1.79M | – | 874 |
|
|
2023
Q3 | $1.79M | Sell |
36,125
-7,837
| -18% | -$388K | ﹤0.01% | 728 |
|
|
2023
Q2 | $3.44M | Sell |
43,962
-551
| -1% | -$43.1K | ﹤0.01% | 664 |
|
|
2023
Q1 | $4.03M | Buy |
44,513
+1,876
| +4% | +$170K | ﹤0.01% | 655 |
|
|
2022
Q4 | $5.03M | Buy |
42,637
+6,299
| +17% | +$743K | ﹤0.01% | 654 |
|
|
2022
Q3 | $6.59M | Buy |
36,338
+2,461
| +7% | +$447K | ﹤0.01% | 638 |
|
|
2022
Q2 | $3.04M | Sell |
33,877
-254
| -0.7% | -$22.8K | ﹤0.01% | 683 |
|
|
2022
Q1 | $5.3M | Buy |
34,131
+943
| +3% | +$146K | ﹤0.01% | 671 |
|
|
2021
Q4 | $9.88M | Sell |
33,188
-245
| -0.7% | -$72.9K | ﹤0.01% | 662 |
|
|
2021
Q3 | $19.3M | Buy |
33,433
+6,844
| +26% | +$3.94M | 0.01% | 617 |
|
|
2021
Q2 | $12.1M | Sell |
26,589
-79
| -0.3% | -$35.9K | ﹤0.01% | 658 |
|
|
2021
Q1 | $14.4M | Sell |
26,668
-626
| -2% | -$337K | ﹤0.01% | 636 |
|
|
2020
Q4 | $24.1M | Buy |
27,294
+508
| +2% | +$449K | 0.01% | 571 |
|
|
2020
Q3 | $16.9M | Buy |
+26,786
| New | +$16.9M | 0.01% | 585 |
|